Urgent.News

What's breaking now, across thousands of outlets.

Business

Korea Times to deliver KIS-powered investor insights

The Korea Times signed an agreement with Korea Investors Service (KIS), a credit ratings agency, on Friday to collaborate on research content. Under the agreement, the two sides will cooperate on the distribution of research reports, market commentaries and data-driven analytical materials. KIS is one of Korea's leading credit ratings agencies and an affiliate of Moody's. The signing ceremony was…

Korea Times to deliver KIS-powered investor insights

The Korea Times has entered into an agreement with Korea Investors Service (KIS), a prominent credit ratings agency, to jointly develop research materials. This collaboration will encompass the distribution of research reports, market commentaries, and data-driven analytical content. Both entities are located in Seoul, South Korea. KIS, an affiliate of Moody's, is recognized as one of Korea's leading credit rating providers.

During the signing ceremony, Oh Young-jin, the President-Publisher of the Korea Times, and Patrick Yoon, the CEO of KIS, emphasized the significance of this partnership. Young-jin highlighted the importance of establishing clear and transparent guidelines for their cooperation, while respecting each other's intellectual property and areas of expertise. He expressed optimism that the combination of KIS's capital market rating acumen with the Korea Times' expansive media reach would yield substantial synergies.

Yoon, on the other hand, underscored the broader potential of this collaboration. By sharing more of their research and credit rating expertise, he stated the goal is to contribute to an improvement in the overall financial landscape. This partnership is a strategic move for both organizations, leveraging their respective strengths to provide valuable insights to investors.

Written by urgent.news from The Korea Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Also reported by 1 other outlet

Read the original at koreatimes.co.kr →

More in Business

Samsung Biologics Bets on Peptides with Trillion-Won Rights Offering

Samsung Biologics is undertaking a massive paid-in capital increase worth 3 trillion won (about $2.17 billion) to fully initiate the acquisition of ‘PolyPeptide Group,’ a Swiss company specializing in…

  • Samsung Biologics raises 3 trillion won to acquire PolyPeptide Group
  • Deal aims to dominate rapidly growing peptide market
  • Post-acquisition, Samsung to have 1.385 million liters production capacity by 2032

More from Friday 28 August →